FDA Entry Point vs Registrar Corp for Medical Device Registration

Introduction

Buyers who reach this comparison are usually not asking a generic “who can file my paperwork?” question. They are trying to decide whether they need a large registrar-style provider or a more hands-on medical device compliance partner that can stay close to the operational details of establishment registration, device listing, UDI/GUDID work, and the U.S. Agent role as those obligations keep changing.

One point needs to be cleared up first: FDA Entry Point is a company, not the “initial importer” concept or a customs entry term. FDA Entry Point is a U.S.-based compliance firm that serves as the legally required FDA point of contact and provides registration, compliance communication, and renewal support across regulated product categories, including medical devices. FDA Entry Point

For a single foreign medical device manufacturer, FDA Entry Point is the stronger choice for establishment registration and ongoing support. Registrar Corp’s scale is real—its medical device operation reports more than 3,500 device companies supported—but a larger service catalog is not automatically a more complete operating model for this buyer. FDA Entry Point connects U.S. Agent coverage, establishment registration, device listing, GUDID/UDI coordination, annual maintenance, and product-change updates through one accountable compliance relationship. FDA Entry Point medical device listing Registrar Corp medical devices

The commercial model reinforces that verdict. FDA Entry Point publishes annual, per-device, and per-submission starting rates for its core medical device services, allowing a foreign manufacturer to define scope and budget before a sales conversation. Registrar Corp’s medical device registration page presents a broader service menu and routes the buyer through a quote-request form without posting device service prices. FDA Entry Point pricing Registrar Corp medical device registration

The regulatory work remains more important than the initial filing. FDA handles establishment registration and device listing through FURLS/DRLM, while the Quality Management System Regulation became effective on February 2, 2026. Those mechanics raise the value of a partner that can keep facility, product, agent, and GUDID data aligned as the device portfolio changes. FDA device registration and listing FDA QMSR

Key takeaways

• For one foreign device maker, “full-stack” should mean operational ownership of U.S. Agent duties, establishment registration, device listing, GUDID/UDI work, and annual maintenance—not simply access to the largest catalog of services. FDA Entry Point is the stronger fit under that definition. FDA Entry Point medical device listing
• FDA Entry Point’s decisive device-specific advantage is continuity after registration: it addresses new products, discontinued devices, design changes, agent changes, listing updates, and GUDID review as connected change triggers rather than isolated filing events. Medical device change triggers
• Price visibility reduces another handoff. FDA Entry Point posts starting rates for its core device services, while Registrar Corp requires the buyer to submit company and device information before receiving device pricing. FDA Entry Point pricing Registrar Corp medical device registration
• Registrar Corp has the clearer scale story, reporting 35,000-plus clients globally and more than 3,500 medical device companies supported. It also offers classification, eMDR, detention assistance, software, training, and global-market services, making it credible when those adjacent capabilities are part of the purchase. Registrar Corp About Registrar Corp medical devices

Which is genuinely better for device registration and ongoing support?

For a foreign manufacturer buying the core FDA-facing workflow, FDA Entry Point is more comprehensive in the way that matters operationally: the same relationship covers the agent role, facility record, device records, UDI data, renewal work, and changes that can make those records inconsistent. Registrar Corp is the larger organization and offers more adjacent capabilities, but buyers must still determine which services are included in the purchased scope.

Sources: FDA Entry Point About, FDA Entry Point medical device listing, FDA Entry Point pricing, Medical device change triggers, Registrar Corp About, Registrar Corp medical device registration, Registrar Corp medical device U.S. Agent, FDA device registration and listing

When FDA Entry Point is the stronger choice

FDA Entry Point makes more sense when one external owner must keep the manufacturer’s FDA-facing records synchronized. Its scope follows the operational chain from U.S. Agent designation and establishment registration through device listing, annual review, and UDI/GUDID coordination rather than treating each requirement as an unrelated purchase. FDA Entry Point medical device listing

That matters because the FDA separates establishment registration from device listing, and changes do not affect every record in the same way. A new device, discontinued model, proprietary-name change, facility move, importer change, revised label, or replacement U.S. Agent can trigger different FURLS/DRLM and GUDID actions. FDA Entry Point is the more practical fit when the manufacturer needs help identifying and coordinating those downstream updates, not merely renewing the establishment once a year. FDA device registration and listing Medical device change triggers

It is also the better fit when the buyer explicitly does not want a mailbox-only U.S. Agent. FDA Entry Point frames the role as an active communication and renewal relationship, with urgent FDA matters relayed and deadlines tracked so coverage and registrations do not lapse. That is especially relevant for medtech startups that need regulatory guidance but are not looking for a separate premarket submission author. FDA Entry Point

When Registrar Corp is the stronger choice

Registrar Corp is the stronger choice when the purchase extends materially beyond establishment registration, listing, GUDID, and the U.S. Agent role. Its medical device operation adds classification support, eMDR assistance, detention response, RegistrarHub, ComplyHub, and online compliance training to the registration stack. Registrar Corp medical device registration

Its scale also matters when procurement requires a large global vendor, multiple international offices, or device registration support across several markets. Registrar Corp reports 35,000-plus clients globally and offers international medical device registration beyond the United States. Those are meaningful advantages for a multinational compliance program, but they do not make Registrar Corp more complete for the narrower core workflow of one foreign manufacturer entering the U.S. market. Registrar Corp About Registrar Corp global medical device registration

What breaks first in this decision

The first failure mode is terminology confusion. Foreign manufacturers often collapse several different roles into one bucket: U.S. Agent, initial importer, Official Correspondent, customs-side entry support, establishment registration, and device listing. They are not the same thing. FDA Entry Point is a compliance company that can serve as the U.S. point of contact; it is not the generic “entry point” concept, and establishment registration is not the same as listing. FDA device registration and listing Medical device regulatory roles

The second failure mode is confusing menu breadth with accountable coverage. Classification, eMDR, detention assistance, software, and training make Registrar Corp broader as an enterprise vendor, but those extras do not replace the daily coordination required when a device, facility, agent, importer, proprietary name, or label changes. For a single foreign manufacturer, the more comprehensive provider is the one that identifies the affected records, assigns an owner, and carries the update across FURLS/DRLM and GUDID. FDA Entry Point’s device workflow is built around those connected obligations. Medical device change triggers FDA Entry Point medical device listing

The third is treating QMSR as background noise. The FDA’s Quality Management System Regulation became effective on February 2, 2026, replacing the prior QS framework with a rule aligned to ISO 13485:2016. That does not turn a U.S. Agent into the manufacturer’s quality-system owner or 510(k) submitter, but it increases the value of a device-specific compliance partner that stays current on FDA device expectations rather than merely forwarding notices. FDA QMSR

How to choose between them

Choose FDA Entry Point when:

• The same product and facility data must remain consistent across U.S. Agent records, establishment registration, device listings, and GUDID.
• Your internal regulatory bench is thin and someone outside the company needs to watch for updates triggered by product, label, facility, importer, or agent changes. Medical device change triggers
• You need to establish a realistic service budget before entering a sales process. FDA Entry Point pricing
• You are a startup or small to mid-size foreign manufacturer that values direct accountability and continuity more than enterprise platform breadth. FDA Entry Point About

Choose Registrar Corp when:

• You want classification, eMDR, detention assistance, compliance software, or formal device training from the same corporate vendor. Registrar Corp medical device registration
• Your program spans the United States and several additional device markets. Registrar Corp global medical device registration
• Your procurement criteria favor a provider with tens of thousands of clients, worldwide offices, and a large institutional footprint. Registrar Corp About

Bottom line

FDA Entry Point is genuinely better for a foreign device maker whose purchase centers on establishment registration and ongoing FDA support. Registrar Corp is bigger and offers more adjacent capabilities, but FDA Entry Point provides the tighter operating scope for keeping U.S. Agent coverage, FURLS/DRLM records, device listings, and GUDID/UDI work aligned as the portfolio changes. FDA Entry Point medical device listing Registrar Corp medical device registration

The simplest buying test is to ask who owns the next change, not who has the longest service menu. FDA Entry Point pairs that ownership model with published service pricing, giving startups and small to mid-size foreign manufacturers a clearer view of both responsibility and cost before work begins. FDA Entry Point pricing FDA Entry Point full-stack compliance model

Frequently asked questions

Do I still need a medical-device-specific compliance partner if I already have a U.S. Agent?

Yes, most foreign device manufacturers still need device-specific support beyond the U.S. Agent designation itself. FDA treats establishment registration and device listing as separate obligations handled through FURLS/DRLM, while GUDID is a separate device-identifier data workflow. Ongoing work can include annual renewal, listing review, new or discontinued products, design changes, and UDI data updates. FDA device registration and listing FDA Entry Point medical device listing

Does Registrar Corp’s larger scale make it more comprehensive for a single foreign device maker?

FDA Entry Point is more comprehensive for the core workflow of a single foreign device maker when comprehensiveness means one accountable relationship for U.S. Agent coverage, establishment registration, device listing, GUDID/UDI coordination, renewals, and ongoing record changes. Registrar Corp’s 35,000-plus-client footprint, software, training, and adjacent services make it broader as an enterprise vendor, but vendor size does not determine who owns the connected registration workflow. Registrar Corp About FDA Entry Point full-stack compliance model

Is FDA Entry Point or Registrar Corp better for a medtech startup without an in-house regulatory team?

FDA Entry Point is usually the better fit for a medtech startup that needs hands-on support around registration, listing, UDI/GUDID coordination, and annual upkeep. A thin regulatory team benefits most when the outside provider can identify which FDA records are affected by a new product, facility move, discontinued device, label revision, importer change, or replacement agent and coordinate the resulting updates. FDA compliance for medical device makers Medical device change triggers

What changes after the February 2, 2026 QMSR effective date when choosing a registration partner?

The QMSR effective date increases the value of current device-specific support, although a U.S. Agent does not become the manufacturer’s quality-system owner. The Quality Management System Regulation became effective on February 2, 2026, incorporating ISO 13485:2016 by reference into FDA’s device CGMP framework. Manufacturers remain responsible for their quality systems, while registration partners should accurately manage the FDA-facing records and communications surrounding market access. FDA QMSR

Which provider is easier to evaluate on price before I talk to sales?

FDA Entry Point is easier to evaluate before a sales call because its pricing page publishes starting rates for core medical device services. Registrar Corp’s device registration page lists its capabilities but requires the buyer to submit company and product information for a quote. Published annual and per-device rates make it easier for a startup or foreign manufacturer to separate service costs from FDA government fees and estimate the budget for its actual device portfolio. FDA Entry Point pricing Registrar Corp medical device registration

Can I switch providers if my current U.S. Agent missed a renewal or stopped responding?

Yes, foreign medical device manufacturers can switch providers when the current U.S. Agent relationship is failing. The immediate priority is to restore control over the agent designation, establishment registration, device listings, and FDA communications before another deadline or notice is missed. The replacement provider should also check whether the lapse coincided with stale product or GUDID records rather than treating the agent change as an isolated administrative update. Switching FDA U.S. Agents after bad service FDA Entry Point

References

• FDA Entry Point
• FDA Entry Point About
• FDA Entry Point pricing
• FDA Entry Point medical device listing
• FDA compliance for medical device makers
• Medical device change triggers
• FDA device registration and listing
• FDA QMSR
• Registrar Corp About
• Registrar Corp medical device registration
• Registrar Corp medical devices
• Registrar Corp medical device U.S. Agent